In 1939 the Eighth Route Army Health Center of the Taihang Mountain Base.
In 1953 Wuhan Pharmaceutical Factory began to develop insulin.
In 1958 the trial production of adrenocorticotropic hormone was successful.
In 1960 Dimercaptopropanol was produced exclusively in China.
In 1966 Gadolinium was the first to successfully develop metronidazole.
In 1976 I developed the Baibai stop eye drops exclusively for clinical use.
In 1979 Production was officially enlarged.
In 1982 Won the National Quality Silver Award.
In 1989 The third-generation quinolone drug-enoxacin was approved for trial production.
In 1991 It was officially approved for production.
In 1994 It was renamed Wuhan Pharmaceutical Group.
In 1999 Wuhan Nuojia Pharmaceutical Co., Ltd.
In 2002 The company realized the "three supers" of comprehensive construction and production output, housing construction and municipal construction output plans, and the annual tax payment for the first time exceeded 10 million yuan.